APA (7th ed.) Citation

H, Z., W, X., G, Z., F, R., F, G., & L, W. (2024). Metabolic dysregulation in myelodysplastic neoplasm: Impact on pathogenesis and potential therapeutic targets. Medical oncology (Northwood, London, England), 42(1), 23. https://doi.org/10.1007/s12032-024-02575-3

Chicago Style (17th ed.) Citation

H, Zhou, Xiang W, Zhou G, Rodrigues-Lima F, Guidez F, and Wang L. "Metabolic Dysregulation in Myelodysplastic Neoplasm: Impact on Pathogenesis and Potential Therapeutic Targets." Medical Oncology (Northwood, London, England) 42, no. 1 (2024): 23. https://doi.org/10.1007/s12032-024-02575-3.

MLA (9th ed.) Citation

H, Zhou, et al. "Metabolic Dysregulation in Myelodysplastic Neoplasm: Impact on Pathogenesis and Potential Therapeutic Targets." Medical Oncology (Northwood, London, England), vol. 42, no. 1, 2024, p. 23, https://doi.org/10.1007/s12032-024-02575-3.